The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC).
Artemisinin-based combination therapies (ACTs) have been recommended by the World Health Organization (WHO) as first-line treatment of uncomplicated Plasmodium falciparum (P. falciparum) malaria since 2005 in Democratic Republic of Congo (DRC) and a regular surveillance of the ACT efficacy is requir...
Main Authors: | Doudou Malekita Yobi, Nadine Kalenda Kayiba, Dieudonné Makaba Mvumbi, Raphael Boreux, Sebastien Bontems, Pius Zakayi Kabututu, Patrick De Mol, Niko Speybroeck, Georges Lelo Mvumbi, Marie-Pierre Hayette |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0237791 |
Similar Items
-
Care-seeking behaviour and socio-economic burden associated with uncomplicated malaria in the Democratic Republic of Congo
by: Nadine Kalenda Kayiba, et al.
Published: (2021-06-01) -
Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018–2019
by: Doudou M. Yobi, et al.
Published: (2021-03-01) -
The landscape of drug resistance in Plasmodium falciparum malaria in the Democratic Republic of Congo: a mapping systematic review
by: Nadine Kalenda Kayiba, et al.
Published: (2023-11-01) -
Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance
by: Doudou M. Yobi, et al.
Published: (2020-03-01) -
Investigation on possible transmission of monkeys' Plasmodium to human in a populations living in the equatorial rainforest of the Democratic republic of Congo
by: Dieudonné Makaba Mvumbi, et al.
Published: (2016-04-01)